BioSpace News Archive

CDI Laboratories, Inc. announced the addition of its SARS-CoV-2 (COVID19) assay platform. The assays use CDI’s VirScan service which can detect antibodies to 1345 individ

Johnson & Johnson (NYSE: JNJ) today announced Lewis Cantley, Ph.D., of Weill Cornell Medicine and NewYork-Presbyterian as the winner of the 2020 Dr. Paul Janssen Award for Biomedical Research

Pharma Executive Brought in to Drive Digital Pill Use Cases [20-August-2020] GAINESVILLE, Fla. , Aug. 20, 2020 /PRNewswire/ -- etectRx ™ , Inc. (etectRx ™ ), a privately held digital health company, today announced the appointment of pharma veteran Valerie Sullivan as its next president and CEO. In late 2019, the company received FDA clearance for its novel ingest

Respiratory Motion Inc. (RMI) today announced that C. Raymond Larkin Jr. will act as a Strategic Advisor to the Company.

Millions of patients rely on the nation’s emergency physicians to help them through life’s worst moments.

Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage immunology company focused on treating and preventing serious infectious diseases, today announced that data from its VIR-2218 clinical program will be featured at the European Association for the Study of the Liver (EASL) Digital International Liver Congress™ from August 27-29, 2020. VIR-2218 is an investigational small interfering ribonucleic acid (siRNA) that mediates RNA interference (R

Galderma is partnering with rosacea sufferer and celebrity stylist, Brad Goreski, for the national awareness campaign, Face Up to Rosacea, to encourage people frustrated with this chronic skin condition to take action by consulting with a dermatologist.

Columbus Children’s Foundation (CCF), a national leading non-profit biotech organization helping children with ultra-rare genetic diseases, announced today that Krystof Bankiewicz, M.D., Ph.D., has been named president and chief executive officer.

Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today that the United States Patent and Trademark Office has issued patent No. 10,744,257 entitled “Devices and Methods for On-Line Whole Blood Treatment” regarding the Company’s Selective Target Antigen Removal System (STARS™) technology. STARS i

AmideBio, LLC, a privately held biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) Offices of Pediatric Therapeutics and Orphan Products Development granted a rare pediatric disease designation to AmideBio’s glucagon analog (AB-G023) for the treatment of congenital hyperinsulinism (CHI). AB-G02